REVOLUTION Medicines Inc

24 sep 2026, 23:01 UTC

Revolution Medicines Inc is trading modestly lower in after-market hours, following a broader market decline and unusual volatility, remaining below its 20-day moving average.

23 sep 2026, 20:07 UTC

Revolution Medicines Inc. shares fell sharply despite receiving FDA Breakthrough Therapy Designation for RASONQUE, amid broader market declines and rising U.S. Treasury yields.

21 sep 2026, 20:02 UTC

Revolution Medicines Inc shares are trading higher as BofA Securities reaffirms a Buy rating and raises the price target to $265.

18 sep 2026, 20:02 UTC

Revolution Medicines Inc shares fell sharply, continuing a decline since Thursday's close, amid broader weakness in the Containers & Packaging sector and high trading volume.

17 sep 2026, 19:36 UTC

Revolution Medicines Inc shares fell modestly after reaching a notable high earlier, currently trading below the 20-day moving average amid broader market weakness.

16 sep 2026, 20:06 UTC

Revolution Medicines Inc shares fell sharply, reversing recent gains, with unusually high trading volume reflecting increased market activity.

15 sep 2026, 23:11 UTC

Revolution Medicines shares declined in after-market trading, remaining below the 20-day moving average amid broader market concerns over inflation and rising U.S. crude inventories.

11 sep 2026, 20:08 UTC

Revolution Medicines Inc shares are higher during Friday's session, despite earlier pulling back from an intraday high. No specific news was identified for the movement.

3 sep 2026, 19:16 UTC

Revolution Medicines Inc shares are higher after positive Phase 1/2 trial results for RASONQUE in advanced RAS mutant non-small cell lung cancer were published.

2 sep 2026, 23:51 UTC

Revolution Medicines shares rise in after-market trading following positive Phase 1/2 data on RASONQUE for advanced RAS mutant non-small cell lung cancer.

1 sep 2026, 23:06 UTC

Revolution Medicines Inc shares are higher in after-market trading, maintaining a stable performance since Tuesday's close despite earlier session volatility.

31 aug 2026, 20:07 UTC

Revolution Medicines Inc shares are lower amid broader market pressures and concerns from the Jackson Hole Economic Symposium regarding inflation and monetary policy tightening.

28 aug 2026, 20:02 UTC

Revolution Medicines shares are lower amid significant selling pressure, despite recent price target increases by UBS and others for its drug RASONQUE.

27 aug 2026, 23:02 UTC

Revolution Medicines Inc shares are higher in after-market trading following FDA approval of RASONQUE for metastatic pancreatic cancer, discussed during an August 26 conference call.

26 aug 2026, 23:21 UTC

Oppenheimer raised Revolution Medicines' price target to $260, citing FDA approval of RASONQUE for advanced pancreatic cancer, as shares trade higher in after-market hours.

25 aug 2026, 20:07 UTC

Revolution Medicines Inc received a "Moderate Buy" rating from brokerages. Needham raised its price target to $240, while shares are trading roughly flat.

24 aug 2026, 20:06 UTC

Revolution Medicines Inc shares are higher today, recovering from an earlier low. The stock has gained since Friday's close amid rising oil prices.

21 aug 2026, 19:46 UTC

Revolution Medicines shares are lower today as Bernstein raised its price target to $179, continuing a trend of three consecutive daily declines.

20 aug 2026, 23:26 UTC

Revolution Medicines Inc. shares were roughly flat in after-market hours, remaining above the 20-day moving average and near the upper end of their one-month range.

19 aug 2026, 19:46 UTC

Revolution Medicines Inc shares are lower Wednesday, pulling back after reaching a session high. The stock has declined since Tuesday's close.

17 aug 2026, 19:51 UTC

Revolution Medicines shares are higher since Friday's close as Baker Bros boosts its stake to 11.4 million shares, valued at $2 billion.

13 aug 2026, 19:36 UTC

Revolution Medicines Inc shares are lower, reaching a session low earlier. This decline follows a cumulative drop since Wednesday's close.

12 aug 2026, 23:16 UTC

Revolution Medicines shares declined in after-market trading, despite earlier gains. The Consumer Price Index report showed a modest rise in consumer prices today.

11 aug 2026, 19:36 UTC

Revolution Medicines Inc is trading lower as broader geopolitical tensions and upcoming U.S. inflation reports weigh on market sentiment.

10 aug 2026, 23:51 UTC

Revolution Medicines Inc. shares were roughly flat in after-market hours, maintaining a position above the 20-day moving average and near the one-month range's upper end.

7 aug 2026, 19:11 UTC

Revolution Medicines Inc shares are higher as the company plans a Phase 3 study and Wedbush raises its price target to $201 from $192.

6 aug 2026, 19:36 UTC

Revolution Medicines Inc is trading higher as RBC Capital and Evercore ISI raise price targets, reflecting growing confidence in the company's clinical pipeline.

5 aug 2026, 23:02 UTC

Revolution Medicines shares lower in after-market trading following a second-quarter loss of $644.4 million and an EPS of -$3.06, missing estimates.

4 aug 2026, 23:06 UTC

Revolution Medicines shares are lower in after-market trading, settling near Tuesday's close. The stock remains above its 20-day moving average.

3 aug 2026, 23:26 UTC

Revolution Medicines Inc shares are trading higher in after-market hours. Broader market sentiment is positive, influenced by declining oil prices and reduced inflation concerns.